This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:
—In The Journal for March 9 (p. 710) there appeared an article by Dr. William Allen Pusey, attacking Thoremedin. In the same issue (p. 700) there appeared an editorial which, assuming that Dr. Pusey's conclusions were correct and incontrovertible, also condemns the remedy.The charge that we should be capable of furnishing to the medical profession a product, the composition of which we intended to keep secret is, in the light of the well-known ethical character of our house, incomprehensible, and especially so in view of the printed announcement in the January number of Squibb's Memoranda, where it was plainly indicated that the publication of the quantitative formula was delayed only for good and sufficient reasons and was to follow in due course. This was certainly the meaning we intended to convey—our purpose being to have the Thoremedin products, as furnished by us according to the Semerak
Weicker T. Messrs. Squibb & Sons Explain About Thoremedin. JAMA. 1912;LVIII(15):1135–1136. doi:10.1001/jama.1912.04260040151025
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: